253 related articles for article (PubMed ID: 3942200)
21. In vivo effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors.
Eguchi K; Kawamoto K; Uozumi T; Ito A; Arita K; Kurisu K
Endocr J; 1995 Apr; 42(2):153-61. PubMed ID: 7627259
[TBL] [Abstract][Full Text] [Related]
22. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
Gómez O; Balsa JA
Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
[TBL] [Abstract][Full Text] [Related]
23. The role of adenosine 3',5'-monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells.
Tam SW; Dannies PS
Endocrinology; 1981 Aug; 109(2):403-8. PubMed ID: 6166464
[TBL] [Abstract][Full Text] [Related]
24. Estrogen increases galanin immunoreactivity in hyperplastic prolactin-secreting cells in Fisher 344 rats.
Hsu DW; el-Azouzi M; Black PM; Chin WW; Hedley-Whyte ET; Kaplan LM
Endocrinology; 1990 Jun; 126(6):3159-67. PubMed ID: 1693569
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules.
Saitoh Y; Koizumi K; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
Anticancer Res; 1986; 6(5):1149-55. PubMed ID: 3800323
[TBL] [Abstract][Full Text] [Related]
26. Effects of estrogen and tamoxifen on the ultrastructural characteristics of female rat prolactin cells as evaluated by immunogold technique.
Erensoy N; Cagatay P; Yilmazer S
Acta Histochem; 2005; 107(3):199-205. PubMed ID: 15993477
[TBL] [Abstract][Full Text] [Related]
27. Correlation study of serum prolactin levels, pituitary weights, number and ultrastructure of pituitary lactotrophs in female Long-Evans rats.
Baird RE; Losinski NE; Kovacs K; Thorner MO
Exp Pathol; 1990; 40(2):95-103. PubMed ID: 2079107
[TBL] [Abstract][Full Text] [Related]
28. Effects of pergolide on diethylstilbestrol-induced rat pituitary hyperplasia.
Lloyd RV; Schmidt K; Nath V
Am J Pathol; 1985 Dec; 121(3):486-95. PubMed ID: 4073221
[TBL] [Abstract][Full Text] [Related]
29. Influence of photoinhibition on the morphology and function of pituitary lactotropes in male golden hamsters.
Cónsole GM; Jurado SB; Petruccelli M; Carino M; Calandra RS; Gómez Dumm CL
Neuroendocrinology; 2002 May; 75(5):316-25. PubMed ID: 12006785
[TBL] [Abstract][Full Text] [Related]
30. Evidence for lactotroph dopamine resistance in idiopathic hyperprolactinemia.
Webb CB; Thominet JL; Barowsky H; Berelowitz M; Frohman LA
J Clin Endocrinol Metab; 1983 Jun; 56(6):1089-93. PubMed ID: 6841551
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fischer 344 rats.
Elias KA; Weiner RI
Endocrinology; 1987 Feb; 120(2):617-21. PubMed ID: 3803294
[TBL] [Abstract][Full Text] [Related]
32. Hyperprolactinemia inhibits gonadotropin-releasing hormone (GnRH) stimulation of the number of pituitary GnRH receptors.
Garcia A; Herbon L; Barkan A; Papavasiliou S; Marshall JC
Endocrinology; 1985 Sep; 117(3):954-9. PubMed ID: 2990879
[TBL] [Abstract][Full Text] [Related]
33. Changes in the ultrastructural distribution of prolactin and growth hormone mRNAs in pituitary cells of female rats after estrogen and bromocriptine treatment, studied using in situ hybridization with biotinylated oligonucleotide probes.
Matsuno A; Ohsugi Y; Utsunomiya H; Takekoshi S; Sanno N; Osamura RY; Watanabe K; Teramoto A; Kirino T
Histochem Cell Biol; 1995 Jul; 104(1):37-45. PubMed ID: 7584558
[TBL] [Abstract][Full Text] [Related]
34. Is there a direct correlation between the activities of various lysosomal enzymes and prolactin secretion in the rat anterior pituitary?
Nagy I; Rappay G; Makara GB; Horvath G; Bacsy E; MacLeod RM
Endocrinology; 1983 Feb; 112(2):470-5. PubMed ID: 6848358
[TBL] [Abstract][Full Text] [Related]
35. Effects of age and long term ovariectomy on prolactin secretion, as assessed by the reverse hemolytic plaque assay.
Sortino MA; Wise PM
Endocrinology; 1989 Jan; 124(1):90-6. PubMed ID: 2491812
[TBL] [Abstract][Full Text] [Related]
36. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
Canonico PL; Valdenegro CA; MacLeod RM
Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
[TBL] [Abstract][Full Text] [Related]
37. [Validity of radioimmunoassay for blood and pituitary prolactin in the male rat. Effect of bromocriptine and thyrotropin-releasing hormone].
André M; Grizard G; Boucher D
C R Seances Soc Biol Fil; 1981; 175(6):792-800. PubMed ID: 6459824
[TBL] [Abstract][Full Text] [Related]
38. Intracellular dynamics in pituitary mammotropes throughout the rat estrous cycle. II. Changes in synthetic and secretory organelles.
Poole MC; Mahesh VB; Costoff A
Am J Anat; 1980 May; 158(1):15-28. PubMed ID: 7191202
[TBL] [Abstract][Full Text] [Related]
39. Prolactin and testosterone: independent circulating levels in hyperprolactinemic and normoprolactinemic amenorrhea. The effect of prolactin suppression by bromocriptine.
Seppälä M; Hirvonen E; Unnérus HA; Ranta T; Laatikainen T
J Clin Endocrinol Metab; 1976 Jul; 43(1):198-200. PubMed ID: 947938
[TBL] [Abstract][Full Text] [Related]
40. Fatty acid profiles in hepatic membranes of rats with different levels of circulating estrogen and prolactin.
Bellini MJ; Carino MH; Tacconi-Gómez Dumm N; Goya RG
Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):470-4. PubMed ID: 16490375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
